2 completed, 2 enrolling by invitation, 1 recruiting. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Enrolling by invitation 2, Recruiting 1 |
| Phase 1 | 2 | Completed 2 |
Follow Adam Boxer: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen B: LM11A-31 LM11A-31, Matching Placebo - PSP - Progressive Supranuclear Palsy | Phase 2 | Enrolling by invitation | Adam Boxer | 147 | 2026-07-29 | 2026-08-12 |
| The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen A: AADvac1 AADvac1, Matching Placebo - PSP - Progressive Supranuclear Palsy | Phase 2 | Enrolling by invitation | Adam Boxer | 146 | 2026-07-29 | 2026-08-13 |
| The Progressive Supranuclear Palsy Clinical Trial Platform AADvac1, LM11A-31 - Progressive Supranuclear Palsy(PSP) | Phase 2 | Recruiting | Adam Boxer | 440 | 2026-07-29 | 2026-10-22 |
| Salsalate in Patients Mild to Moderate Alzheimer's Disease Salsalate, Placebo - Alzheimer Disease | Phase 1 | Completed | Adam Boxer | 40 | 2017-07-21 | 2025-04-16 |
| A 6 Month, Open-Label, Pilot Futility Clinical Trial of Oral Salsalate for Progressive Supranuclear Palsy Salsalate - Progressive Supranuclear Palsy | Phase 1 | Completed | Adam Boxer | 10 | 2015-04-01 | 2021-04-01 |
Supranuclear Palsy, Progressive (4) · Frontotemporal Dementia (2) · Alzheimer Disease (1)
AADvac1 (2) · LM11A-31 (2) · salicylsalicylic acid (2)
United States (5)
Anne-Marie Wills, MD (3) · Irene Litvan, MD (3) · Julio Rojas-Martinez, MD, PhD (3)
R01AG085029 (3)